www.medicago.com/en
Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine antigens in non-transgenic plants.
News
-
19/01/12
Medicago unveils positive results of initial studies for rabies vaccine -
16/01/12
Medicago inks alliance with Cellectis plant sciences -
30/06/11
Medicago reports positive, phase 2 final study results for Avian flu vaccine -
08/06/11
Medicago reports solid preliminary phase one results for seasonal flu vaccine -
11/01/11
Medicago to collaborate on multi-million US govt' grant for avian flu vaccine -
22/12/10
Medicago completes first part of phase II human trial for H5N1 Avian flu vaccine -
26/11/10
Medicago and Genopole extend partnership for the development of commercial-scale facility in France -
10/08/10
Medicago up 3.5% on award of $21m grant from US Department of Defense -
02/09/09
Medicago in collaboration deal for influenza vaccines in Saudi Arabia and other territories -
30/07/09
Medicago’s Swine flu vaccine candidate shows 100 pct positive response after single dose in animals
Recent Sector News
-

Dow higher after non-farm payroll data, Tyson Foods in focus
The 243,000 increase in payrolls was the most since April and exceeded all forecasts in a Bloomberg survey by a wide margin.
-

US futures rally as employment jumps, jobless rate drops to 8.3%
The US created 243,000 jobs in January, according to the latest figures from the US Labor Bureau, with the unemployment rate easing down to 8.3 percent from 8.5 percent.
-

Dow points up ahead of non-farm payrolls, AON, Wynn in focus
US equity markets looked set to open higher Friday as a new report on the US employment situation will provide more clues about the strength of the economic recovery.
-

January retail sales see Costco, Limited Brands, Target as victors, among others
In what is typically the smallest sales month of the year, many retailers, including Costco (NASDAQ:COST), Limited Brands (NYSE:LTD), and Target Corp (NYSE:TGT) well beat Street expectations for same store sales despite being one of the warmest Januarys in 50 years.
-

Facebook to update status to "public" with $5 bln IPO
Social networking site Facebook late Wednesday filed regulatory documents as it looked to raise $5 billion from an initial public offering.
-

Chrysler leads US auto sales growth in January, GM sales drop
Chrysler led US auto sales growth in January with an impressive 44 percent jump that far outpaced a modest seven percent gain at rival Ford (NYSE:F) and a six percent drop for GM (NYSE:GM), according to industry data released Wednesday.
What do others think of Medicago
Investors interested in Medicago recently viewed
-
NeoStem (NYSE AMEX: NBS) . -
Xenetic Biosciences (AIM: XEN) Innovators in development of drugs and vaccines -
Epistem (AIM: EHP) Biotechnology company applying its expertise in epithelial stem cells -
ImmunoCellular Therapeutics (OTCBB: IMUC) . -
Renovo Group Plc (LSE: RNVO) Renovo: Improving scar appearance and enhancing wound healing


















